Real-world evidence (RWE) provides a comprehensive view of how health interventions perform in everyday clinical settings. Unlike clinical trials, which are controlled and selective, RWE reflects the diverse and practical experiences of patients and healthcare systems, offering valuable data for decision-making.
RWE reflects the varied experiences of real patients in everyday clinical practice, capturing a broader spectrum of outcomes and scenarios than controlled trials.
Our RWE analyses provide compelling evidence of a product’s value in real-world settings, supporting reimbursement and market access negotiations.
Clevidence analysed real data on health performance indicators to assess the impact of the reduction in NHS medical consultations on patient outcomes, particularly on hypertension control.
“
Our modelling technique found that the number of patients with controlled hypertension fell significantly over this period. The analysis allowed us to estimate the potential impact on morbidity and mortality and provide important insights for health policy discussions.”
Clevidence provides expert health technology assessments and market access solutions, ensuring evidence-based decisions for optimal healthcare outcomes.
Cofinanciado por: